Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP218981.RA935cT0cqkSfJlrmEulPtFDWTDe3bixHwQHcurwvpDkY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP218981.RA935cT0cqkSfJlrmEulPtFDWTDe3bixHwQHcurwvpDkY130_assertion type Assertion NP218981.RA935cT0cqkSfJlrmEulPtFDWTDe3bixHwQHcurwvpDkY130_head.
- NP218981.RA935cT0cqkSfJlrmEulPtFDWTDe3bixHwQHcurwvpDkY130_assertion description "[Most fibroadenomas showed weak positivity for ET-1 (83%) and ET-3 (67%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP218981.RA935cT0cqkSfJlrmEulPtFDWTDe3bixHwQHcurwvpDkY130_provenance.
- NP218981.RA935cT0cqkSfJlrmEulPtFDWTDe3bixHwQHcurwvpDkY130_assertion evidence source_evidence_literature NP218981.RA935cT0cqkSfJlrmEulPtFDWTDe3bixHwQHcurwvpDkY130_provenance.
- NP218981.RA935cT0cqkSfJlrmEulPtFDWTDe3bixHwQHcurwvpDkY130_assertion SIO_000772 10672062 NP218981.RA935cT0cqkSfJlrmEulPtFDWTDe3bixHwQHcurwvpDkY130_provenance.
- NP218981.RA935cT0cqkSfJlrmEulPtFDWTDe3bixHwQHcurwvpDkY130_assertion wasDerivedFrom befree-20140225 NP218981.RA935cT0cqkSfJlrmEulPtFDWTDe3bixHwQHcurwvpDkY130_provenance.
- NP218981.RA935cT0cqkSfJlrmEulPtFDWTDe3bixHwQHcurwvpDkY130_assertion wasGeneratedBy ECO_0000203 NP218981.RA935cT0cqkSfJlrmEulPtFDWTDe3bixHwQHcurwvpDkY130_provenance.